Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $199 Million - $229 Million
1,370,500 Added 51.79%
4,016,600 $651 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $72.7 Million - $79.4 Million
-503,200 Reduced 15.98%
2,646,100 $387 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $91.5 Million - $96 Million
-589,600 Reduced 15.77%
3,149,300 $498 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $29.1 Million - $31.7 Million
199,800 Added 5.65%
3,738,900 $586 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $86.5 Million - $96.9 Million
-555,400 Reduced 13.56%
3,539,100 $551 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $119 Million - $128 Million
-771,000 Reduced 15.85%
4,094,500 $678 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $20.6 Million - $24.6 Million
136,400 Added 2.88%
4,865,500 $754 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $83.4 Million - $93.6 Million
-520,500 Reduced 9.92%
4,729,100 $835 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $281 Million - $313 Million
1,744,000 Added 49.75%
5,249,600 $858 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.